| Structure | Chemical Name | CAS | MF |
|
(3S)-3-Amino-1,3,4,5-tetrahydro-2H-1-benzazepin-2-one L(+)-Tartaric acid
|
155300-49-5
|
C14H18N2O7
|
|
Alisol E 23-acetate
|
155301-58-9
|
C32H52O6
|
|
[2-(2-NITRO-PHENYL)-2-OXO-ETHYL]-CARBAMIC ACID TERT-BUTYL ESTER
|
155301-81-8
|
C13H16N2O5
|
|
[2-(2-AMINO-PHENYL)-2-OXO-ETHYL]-CARBAMIC ACID TERT-BUTYL ESTER
|
155301-82-9
|
C13H18N2O3
|
|
1-(tert-butoxycarbonyl)-4,4-dimethylpiperidine-2-carboxylic acid
|
155302-06-0
|
C13H23NO4
|
|
TERT-BUTYL 4-(1H-INDOL-3-YL)-3,6-DIHYDROPYRIDINE-1(2H)-CARBOXYLATE
|
155302-27-5
|
C18H22N2O2
|
|
4-(1H-Indol-3-yl)piperidine-1-carboxylic acid tert-butyl ester
|
155302-28-6
|
C18H24N2O2
|
|
5-(2-(bis(2-aminoethyl)amino)ethylamino)naphthalene-1-sulfonic acid
|
155303-18-7
|
C16H24N4O3S
|
|
6,7-DIIODOBENZO(1,4)DIOXAN
|
155303-91-6
|
C8H6I2O2
|
|
Thiourea, N-2,3-butadienyl-N-(4-methylphenyl)- (9CI)
|
155304-03-3
|
C12H14N2S
|
|
3,4-Isoxazoledicarboxylicacid,5-phenyl-,diethylester(9CI)
|
155304-40-8
|
C15H15NO5
|
|
10-(2-Benzothiazolyl)-2,3,6,7-tetrahydro-1,1,7,7-tetramethyl-1H,5H,11H-(1)benzopyropyrano(6,7-8-I,j)quinolizin-11-one
|
155306-71-1
|
C26H26N2O2S
|
|
palmitoylcarnitine isopropyl ester
|
155309-04-9
|
C26H52NO4+
|
|
4H-1,3,4-Oxadiazine,2-(4-ethoxyphenyl)-5,6-dihydro-(9CI)
|
155309-71-0
|
C11H14N2O2
|
|
3-AMino-2,2-difluoropropan-1-ol
|
155310-11-5
|
C3H7F2NO
|
|
2-Fluoro-5-methyldiphenylamine
|
155310-23-9
|
C13H12FN
|
|
Molybdenum(VI) dioxide bis(1,1,1-trifluoroacetylacetonate)
|
155311-12-9
|
C10H8F6MoO6
|
|
L-2-AMINO-3-[THIOMETHYL-1-(1-OXYL-2,2,5,5-TETRAMETHYL-3-PYRROLIN-3-YL)]PROPANOIC ACID
|
155313-72-7
|
C12H21N2O3S*
|
|
Mangafodipir
|
155319-91-8
|
C22H30N4O14P2.Mn
|
|
(S)-Sulforaphane
|
155320-20-0
|
C6H11NOS2
|
|
(S)-2-METHOXYCYCLOHEXANONE
|
155320-76-6
|
C7H12O2
|
|
norchloroepibatidine
|
155322-26-2
|
C11H14N2
|
|
1,3-Dioxolane-4-carbonyl chloride, 2,2,5-trimethyl-, (4S,5R)- (9CI)
|
155322-89-7
|
C7H11ClO3
|
|
2(3H)-Furanone, 5-acetyldihydro-4-methyl-, (4S-cis)- (9CI)
|
155322-90-0
|
C7H10O3
|
|
(3R)-3-[(S)-1-(METHYLAMINO)ETHYL]PYRROLIDINE
|
155322-92-2
|
C7H16N2
|
|
Pyrrolo[1,2-a]pyrazine-3-methanol, octahydro-, (3S-cis)- (9CI)
|
155322-93-3
|
C8H16N2O
|
|
2-Piperazinemethanol,5-(1-methylethyl)-,(2S-trans)-(9CI)
|
155322-94-4
|
C8H18N2O
|
|
Pyrrolo[1,2-a]pyrazine-1,4-dione, hexahydro-3-(hydroxymethyl)-, (3R-cis)- (9CI)
|
155322-95-5
|
C8H12N2O3
|
|
2,5-Piperazinedione,3-(hydroxymethyl)-6-(1-methylethyl)-,(3R,6S)-(9CI)
|
155322-96-6
|
C8H14N2O3
|
|
(+)-CHIRACAMPHOX
|
155323-17-4
|
C11H17NO2
|
|
Pyrenophorol [HelMidiol]
|
155326-45-7
|
C16H24O6
|
|
hemoglobin Kurdistan
|
155328-28-2
|
|
|
|
hemoglobin Sinai-Baltimore
|
155328-29-3
|
|
|
2-[(5-MERCAPTO-1,3,4-THIADIAZOL-2-YL)THIO]-N-PROPYLACETAMIDE
|
155329-60-5
|
C7H11N3OS3
|
|
6-cyclopropylidene-3-methyl-2-hexen-1-yl pyrophosphate
|
155330-43-1
|
C10H18O7P2
|
|
(2-BUTYL-1H-INDOL-3-YL)(4-METHOXYPHENYL)METHANONE
|
155335-09-4
|
C20H21NO2
|
|
alpha-D-erythro-Hex-2-enopyranoside,ethyl2,3-dideoxy-4,6-O-(1-methylethylidene)-(9CI)
|
155337-42-1
|
C11H18O4
|
|
N-Cyclobutylaniline(WXC03097)
|
155342-90-8
|
C10H13N
|
|
5H-Indeno[5,6-d]-1,3-dioxol-6-amine, 6,7-dihydro-, hydrochloride
|
155344-90-4
|
C10H12ClNO2
|
|
5-cyano-N-(2-pyridyl)indole
|
155346-19-3
|
C14H9N3
|
|
3-methyl-N-(4-pyridyl)indole
|
155346-20-6
|
C14H12N2
|
|
tilisolol hydrochloride
|
155346-81-9
|
C17H25ClN2O3
|
|
Fluconazole (hydrate)
|
155347-36-7
|
C13H14F2N6O2
|
|
1H-Pyrazol-3-amine, 1-(chloroacetyl)- (9CI)
|
155347-67-4
|
C5H6ClN3O
|
|
1H-Pyrazol-5-amine, 1-(chloroacetyl)- (9CI)
|
155347-68-5
|
C5H6ClN3O
|
|
Cyclohexanemethanol, 3-hydroxy-4-(1-methylethyl)-, [1R-(1alpha,3ba,4ba)]- (9CI)
|
155348-04-2
|
C10H20O2
|
|
p-Menthane-1,3,8-triol
|
155348-06-4
|
C10H20O3
|
|
Cyclohexanemethanol, 3-hydroxy-4-(1-methylethyl)-, [1S-(1alpha,3ba,4ba)]- (9CI)
|
155348-07-5
|
C10H20O2
|
|
5-Oxazolidinone,4,4-dimethyl-2-(1-methylethenyl)-(9CI)
|
155352-02-6
|
C8H13NO2
|
|
|
9,12-Octadecadienoic acid (Z,Z)-, polymer with 2,2-bis(hydroxymethyl)-1,3-propanediol, 1,3-isobenzofurandione and α-methyl-ω-hydroxypoly( oxy-1,2-ethanediyl)
|
155355-26-3
|
|
|
|
mtrR protein
|
155359-99-2
|
|
|
8-(3,5-difluorophenyl)-1,4-dioxaspiro(4,5)decan-8-ol
|
155366-01-1
|
C14H16F2O3
|
|
BOC-DL-5-METHYL-1,2,3,4-TETRAHYDROISOQUINOLINE-3-CARBOXYLIC ACID, 98
|
155367-45-6
|
C16H21NO4
|
|
DL-2-BOC-7-(ETHYL)-1,2,3,4-TETRAHYDROISOQUINOLINE-3-CARBOXYLIC ACID
|
155367-48-9
|
C17H23NO4
|
|
Fmoc-3-Aminomethylbenzoic acid
|
155369-11-2
|
C23H19NO4
|
|
2-(4-FLUOROPHENYL)-2,3-DIHYDRO-4(1H)-QUINOLINONE
|
155370-03-9
|
C15H12FNO
|
|
1-Ethyl-3-methylimidazolium hexafluorophosphate
|
155371-19-0
|
C6H11F6N2P
|
|
PACLITAXEL SIDE CHAIN 2
|
155371-59-8
|
C25H33NO3Si
|
|
1-(2-PYRIDYL)-2-(2-NITROBENZYL)ALKYNE
|
155372-21-7
|
C13H8N2O2
|
|
1,3-Cyclohexanedione, 2-(chloroacetyl)-5,5-dimethyl- (9CI)
|
155372-77-3
|
C10H13ClO3
|
|
1H-Imidazole-4-carbonitrile,2-amino-1-methyl-(9CI)
|
155372-96-6
|
C5H6N4
|
|
1H-Imidazole-5-carbonitrile,2-amino-1-methyl-(9CI)
|
155372-97-7
|
C5H6N4
|
|
Diethyl 7-oxo-4,7-dihydropyrazolo[1,5-a]-pyrimidine-3,6-dicarboxylate
|
155374-25-7
|
C12H13N3O5
|
|
2-Propenamide,3-(2-pyridinyl)-,(E)-(9CI)
|
155375-22-7
|
C8H8N2O
|
|
2-Propenamide,3-(2-pyridinyl)-,(Z)-(9CI)
|
155375-23-8
|
C8H8N2O
|
|
6-Trifluoromethyl-pyridine-2-carboxylic acid methyl ester
|
155377-05-2
|
C8H6F3NO2
|
|
ETHYL 3-(TRIFLUOROMETHYL)PYRAZOLE-4-CARBOXYLATE
|
155377-19-8
|
C7H7F3N2O2
|
|
4-MERCAPTOCINNAMIC ACID
|
155378-75-9
|
C9H8O2S
|
|
4-AMINO-3-NITRO-5-ISOPROPYLANILINE
|
155379-81-0
|
C9H13N3O2
|
|
4-AMINO-3-NITRO-5-METHYLANILINE
|
155379-82-1
|
C7H9N3O2
|
|
4-AMINO-3-NITRO-2,5-DIMETHYLANILINE
|
155379-83-2
|
C8H11N3O2
|
|
Methyl 2-(4-(hydroxyMethyl)phenyl)acetate
|
155380-11-3
|
C10H12O3
|
|
methyl(2E)-[2-(chloromethyl)phenyl](methoxyimino)acetate
|
155380-13-5
|
C9H6ClNO
|
|
Cyclobutanecarboxylic acid, 1-formyl-, methyl ester (9CI)
|
155380-49-7
|
C7H10O3
|
|
N-Demethyltilmicosin
|
155381-65-0
|
C45H78N2O13
|
|
2H-Pyrano[4,3-d]oxazole,4-ethoxyhexahydro-1,6-dimethyl-,[3aR-(3aalpha,4alpha,6alpha,7aalpha)]-(9CI)
|
155382-33-5
|
C10H19NO3
|
|
2H-Pyrano[4,3-d]oxazol-2-one,4-ethoxyhexahydro-1,6-dimethyl-,[3aR-(3aalpha,4bta,6alpha,7abta)]-(9CI)
|
155382-41-5
|
C10H17NO4
|
|
|
1,2-Benzenedicarboxylic acid, dibutyl ester, polymer with methyl 2-methyl-2-propenoate, 2-methyl-2-propenoic acid and octadecyl 2-methyl-2-propenoate, 2,2-azobis2-methylpropanenitrile-initiated
|
155382-84-6
|
|
|
3,4-Dichloro-2-methoxybenzoic acid
|
155382-86-8
|
C8H6Cl2O3
|
|
7-TERT-BUTYL-1-METHYLPYRENE
|
155386-57-5
|
C21H20
|
|
TERT-BUTYL 2-HYDROXY-5-NITROBENZOATE
|
155388-63-9
|
C11H13NO5
|
|
Benzoic acid, 5-amino-2-hydroxy-, 1,1-dimethylethyl ester (9CI)
|
155388-93-5
|
C11H15NO3
|
|
3-Pyridinecarboxylicacid,1-ethyl-1,2,5,6-tetrahydro-(9CI)
|
155394-42-6
|
C8H13NO2
|
|
2-(2-FURYL)BENZONITRILE
|
155395-45-2
|
C11H7NO
|
|
4-OXOADAMANTANE-1-CARBOXAMIDE
|
155396-16-0
|
C11H15NO2
|
|
(2R,4S,5R)-3-(tert-butoxycarbonyl)-2-(4-Methoxyphenyl)-4-phenyloxazolidine-5-carboxylic acid
|
155396-69-3
|
C22H25NO6
|
|
2-Piperidinone, 1-methyl-3-(2,2,2-trifluoro-1-hydroxyethylidene)- (9CI)
|
155398-07-5
|
C8H10F3NO2
|
|
4-BENZYL-3-PENT-4-ENOYL-1,3-OXAZOLIDIN-2-ONE
|
155399-10-3
|
C15H17NO3
|
|
(E)-3-(3-Hydroxy-4-methoxyphenyl)-2-propenoic acid ethyl ester
|
155401-23-3
|
C12H14O4
|
|
1-palMitoyl-2-cholesterylheMisuccinoyl-sn-glycero-3-phosphocholine
|
155401-40-4
|
C55H98NO10P
|
|
1-oleoyl-2-cholesterylheMisuccinoyl-sn-glycero-3-phosphocholine
|
155401-41-5
|
C57H100NO10P
|
|
5-AMINO-2-IODOBENZOTRIFLUORIDE
|
155403-06-8
|
C7H5F3IN
|
|
Pemetrexed
|
155405-79-1
|
C12H13BrO3
|
|
4-[2-(2-Amino-4,7-dihydro-4-oxo-1H-pyrrolo[2,3-d]pyrimidin-5-yl)ethyl]benzoic acid methyl ester
|
155405-80-4
|
C16H16N4O3
|
|
N-[4-[2-(2-Amino-4,7-dihydro-4-oxo-3H-pyrrolo[2,3-d]pyrimidin-5-yl)ethyl]benzoyl]-L-glutamic acid 1,5-dimethyl ester
|
155405-81-5
|
C22H25N5O6
|
|
Ethanone, 2-bromo-1-cycloheptyl- (9CI)
|
155412-18-3
|
C9H15BrO
|
|
3-DIMETHYLAMINOMETHYL-BENZOIC ACID
|
155412-73-0
|
C10H13NO2
|
|
CCK-B Receptor Antagonist 2
|
155412-88-7
|
C27H28N6O3
|
|
CHEMBRDG-BB 9003285
|
155412-95-6
|
C12H13N3OS
|
|
CSH 087
|
155413-71-1
|
C19H24ClNO3
|